TimesSquare Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FLAM
HRCM
TimesSquare Capital Management's ATRC Position: Q2 2024 in Review
TimesSquare Capital Management sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 854,547 shares — an estimated $26M sold.
TimesSquare Capital Management first reported a position in ATRC in Q2 2020 and held it in 16 quarters. The position peaked at $87.1M in Q1 2021. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.
- TimesSquare Capital Management reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
- TimesSquare Capital Management sold 854,547 AtriCure shares in Q2 2024, an estimated $26M.
- TimesSquare Capital Management first reported a position in AtriCure in Q2 2020 and held it in 16 quarters.
- TimesSquare Capital Management's AtriCure position peaked at $87.1M in Q1 2021.
- 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.
Based on TimesSquare Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.